Mar 24, 2025, 10:16
Myeloma Paper of the Day, March 24th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of VRd vs. VPd as induction in high-risk newly diagnosed myeloma shows VGPR or better in 52% of patients on VRd vs. 90.47% with VPd (p-value 0.003), average OS 27 and 21-months (p=0.801), PFS 27 and 20-months for VRd and VPd.”
“VRd vs. VPd as induction therapy in high-risk newly diagnosed multiple myeloma”
Authors: Chun Yan Li, Long Zhong, Dan Gui Chen, Fu Sheng Yao and Hong Yan.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 24, 2025, 10:17
Mar 24, 2025, 10:16
Mar 24, 2025, 09:54
Mar 24, 2025, 09:34
Mar 24, 2025, 09:15
Mar 24, 2025, 09:15
Mar 24, 2025, 08:58